Matt Phipps
Stock Analyst at William Blair
(3.15)
# 2,560
Out of 5,096 analysts
628
Total ratings
44.4%
Success rate
1.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matt Phipps
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | Reiterated: Hold | n/a | $63.02 | - | 64 | Oct 29, 2026 | |
| GMAB Genmab | Reiterated: Buy | n/a | $54.92 | - | 29 | Oct 23, 2026 | |
| JSPR Jasper Therapeutics | Initiated Coverage: Buy | $0.5 | $0.508 | -1.57% | 19 | Oct 14, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | n/a | $14.93 | - | 27 | Oct 2, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | n/a | $13.93 | - | 7 | Sep 30, 2026 | |
| ABBV AbbVie | Reiterated: Buy | n/a | $288.84 | - | 13 | Sep 28, 2026 | |
| AUTL Autolus Therapeutics | Reiterated: Buy | n/a | $1.42 | - | 44 | Sep 25, 2026 | |
| KYTX Kyverna Therapeutics | Reiterated: Buy | n/a | $5.22 | - | 1 | Sep 24, 2026 | |
| AMGN Amgen | Reiterated: Buy | n/a | $465.45 | - | 43 | Sep 22, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | n/a | $0.7675 | - | 9 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.56 | - | 16 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.85 | - | 1 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.01 | - | 18 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.35 | - | 23 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.74 | - | 15 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $874.97 | - | 15 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.80 | - | 20 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $120.04 | - | 49 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.46 | - | 20 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.94 | - | 2 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.202 | - | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $109.31 | - | 14 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $29.66 | - | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.09 | - | 9 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.76 | - | 11 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $136.01 | - | 1 | Jan 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $117 | $41.24 | n/a | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $82.25 | n/a | 1 | Sep 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.53 | n/a | 19 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.04 | n/a | 8 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $553.15 | n/a | 1 | Jun 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $220.83 | n/a | 1 | Jun 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9801 | n/a | 11 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.472 | n/a | 5 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1.2 | $7.34 | n/a | 1 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.6354 | n/a | 13 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $146.33 | n/a | 19 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.48 | n/a | 14 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0001 | n/a | 11 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.43 | n/a | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $249.01 | n/a | 26 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $36.95 | n/a | 1 | Jun 11, 2021 |
Bristol-Myers Squibb Company
Oct 29, 2026
Reiterated: Hold
Price Target: n/a
Current: $63.02
Upside: -
Genmab
Oct 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $54.92
Upside: -
Jasper Therapeutics
Oct 14, 2026
Initiated Coverage: Buy
Price Target: $0.5
Current: $0.508
Upside: -1.57%
Cullinan Therapeutics
Oct 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.93
Upside: -
Jade Biosciences
Sep 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.93
Upside: -
AbbVie
Sep 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $288.84
Upside: -
Autolus Therapeutics
Sep 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.42
Upside: -
Kyverna Therapeutics
Sep 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.22
Upside: -
Amgen
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $465.45
Upside: -
Compass Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.7675
Upside: -
Sep 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.56
Upside: -
Sep 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $1.85
Upside: -
Sep 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.01
Upside: -
Sep 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.35
Upside: -
Sep 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.74
Upside: -
Sep 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $874.97
Upside: -
Aug 31, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.80
Upside: -
Aug 19, 2026
Reiterated: Hold
Price Target: n/a
Current: $120.04
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $17.46
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.94
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.202
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $109.31
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $29.66
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.09
Upside: -
Aug 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $10.76
Upside: -
Jan 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $136.01
Upside: -
Oct 11, 2025
Reiterated: Buy
Price Target: $117
Current: $41.24
Upside: n/a
Sep 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $82.25
Upside: n/a
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $6.53
Upside: n/a
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $11.04
Upside: n/a
Jun 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $553.15
Upside: n/a
Jun 7, 2025
Reiterated: Hold
Price Target: n/a
Current: $220.83
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $0.9801
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $0.472
Upside: n/a
Mar 29, 2025
Initiated Coverage: Buy
Price Target: $1.2
Current: $7.34
Upside: n/a
Dec 29, 2022
Rated: Hold
Price Target: n/a
Current: $0.6354
Upside: n/a
Jan 3, 2022
Reiterated: Buy
Price Target: n/a
Current: $146.33
Upside: n/a
Dec 7, 2021
Reiterated: Buy
Price Target: n/a
Current: $8.48
Upside: n/a
Dec 7, 2021
Reiterated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Nov 19, 2021
Reiterated: Buy
Price Target: n/a
Current: $1.43
Upside: n/a
Jul 23, 2021
Rated: Buy
Price Target: n/a
Current: $249.01
Upside: n/a
Jun 11, 2021
Reiterated: Buy
Price Target: n/a
Current: $36.95
Upside: n/a